NCT02702206View on ClinicalTrials.gov

Effect of Ultrasound-guided Hyaluronic or Corticosteroid Injections in Patients With Chronic Subacromial Bursitis

NACompletedINTERVENTIONAL

Enrollment

207

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions

Shoulder PainSubdeltoid BursitisSubacromial Bursitis

Interventions

DRUG

corticosteroids

under US guidance, 2ml triamcinolone (1ml/10mg), 0.5ml distilled water and 1ml 1% lidocaine

DRUG

hyaluronic acid

under US guidance, 2.5ml HA (ARTZ, 1% sodium hyaluronate solution, 10mg/mL, molecular weight 0.9x106Da) and 1ml 1% lidocaine

DRUG

normal saline

under US guidance, 2.5ml normal saline (placebo group). 0.5ml distilled water and 1ml 1% lidocaine

Trial Locations (1)

Unknown

Shin Kong Wu Ho-Su Memorial Hospital, Taipei

All Listed Sponsors

collaborator

Ministry of Science and Technology, Taiwan

OTHER_GOV

lead

Shin Kong Wu Ho-Su Memorial Hospital

OTHER

NCT02702206 - Effect of Ultrasound-guided Hyaluronic or Corticosteroid Injections in Patients With Chronic Subacromial Bursitis | Biotech Hunter | Biotech Hunter